What's New in Washington: 10 Things You Need to Know - May 5 Edition

May 5, 2017

Reading Time : 1 min

Consequently, President Trump and moderate House Republicans, led by Rep. Fred Upton (R-MI), reached an agreement on May 3 to add $8 billion in funding to the AHCA to provide financial assistance in purchasing coverage to people with pre-existing conditions. The final amendment tipped the balance in House Republicans’ favor, and the House voted 217 to 213 to approve the AHCA on May 4. The bill now goes to the Senate for consideration, where its fate remains uncertain.

Click here to view the 10 important things that we believe are worth focusing on from the last two weeks.

Share This Insight

Previous Entries

Deal Diary

April 12, 2023

Read More

Deal Diary

2022-12-15

On December 14, 2022, the Securities and Exchange Commission (SEC) adopted amendments regarding Rule 10b5-1 insider trading plans and related disclosures. The amendments aim to strengthen investor protections concerning insider trading and to help shareholders understand when and how insiders are trading in securities for which they may at times have material nonpublic information (MNPI). In light of these amendments, issuers should review and revise, if needed, their insider trading policies and equity grant policies.

Read more.

...

Read More

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.